Home › Funds › AMI ASSET MANAGEMENT CORP › CYTK

AMI ASSET MANAGEMENT CORP position in CYTK

CYTOKINETICS INC · Health Care

AMI ASSET MANAGEMENT CORP reported holding 14,800 shares of CYTK (CYTOKINETICS INC) in its Q3 2026 13F filing — a position valued at US$975K, representing 0.06% of its reported portfolio and ranking #50 among its reported holdings. AMI ASSET MANAGEMENT CORP has disclosed CYTK holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)14.80K sh
Reported value held$975.47K
Portfolio Weight0.06%
First reportedQ3 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How AMI ASSET MANAGEMENT CORP's CYTK position evolved

AMI ASSET MANAGEMENT CORP first disclosed a stake in CYTK in Q3 2025 at 15,283 shares (US$840K). The position peaked in Q2 2026 at 14,261 shares, worth US$1.2M. Across 5 filings, AMI ASSET MANAGEMENT CORP increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 14,800 shares valued at US$975K — an increase of 539 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2025 15.28K $839.95K New
Q4 2025 14.28K $907.35K Reduce
Q1 2026 14.82K $976.52K Add
Q2 2026 14.26K $1.21M Reduce
Q3 2026 14.80K $975.47K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CYTK and 13F data

CYTK (CYTOKINETICS INC) is a Health Care company. 44 other funds we track also report a position in CYTK — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.59B), Avoro Capital Advisors LLC (US$425.9M), RTW INVESTMENTS, LP (US$243.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CYTK

All CYTK fund holders →

FAQ

How long has AMI ASSET MANAGEMENT CORP held CYTK?

AMI ASSET MANAGEMENT CORP has disclosed CYTK holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is AMI ASSET MANAGEMENT CORP's current position in CYTK?

As of Q3 2026, AMI ASSET MANAGEMENT CORP holds 14.80K shares of CYTK (CYTOKINETICS INC), valued at $975.47K, representing 0.06% of its reported portfolio and ranking #50.

Has AMI ASSET MANAGEMENT CORP been buying or selling CYTK?

In the latest 13F filing (Q3 2026), AMI ASSET MANAGEMENT CORP increased its position in CYTK. The position peaked in Q2 2026 at 14.26K shares.

Which other funds hold CYTK?

Other major institutional holders of CYTK include T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, RTW INVESTMENTS, LP, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.